ZYRTEC-D 12 HOUR Extended Release tablets

Pfizer Inc

Revision date : 2007-12-18

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 4
Safety risk rating 1
Environmental risk rating 5

Note: Ingredients listed on restricted chemical lists

EC/CAS

7631-86-9

Name of the chemical

Silver adsorbed on silicon dioxide

Concentration

N/A

EC/CAS

9004-34-6

Name of the chemical

cellulose

Concentration

N/A

EC/CAS

13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

N/A

EC/CAS

9004-65-3

Name of the chemical

methylhydroxypropylcellulose

Concentration

N/A

EC/CAS

25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

N/A

EC/CAS

418-260-2

Name of the chemical

Kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat; [Gehalt an N,N-Dimethylformamid (EG-Nr. 200-679-5) ≥ 0,5 %] (790/2009)

Concentration

N/A

EC/CAS

209-150-3

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

N/A

EC/CAS

236-675-5

Name of the chemical

Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)

Concentration

N/A

General Information

Revision date

2007-12-18

Product name

ZYRTEC-D 12 HOUR Extended Release tablets

Icons in SDS

Company Information

company name

Pfizer Inc

e-mail address of the competent person responsible for the Safety Data Sheet

pfizer-MSDS@pfizer.com

GHS Information

Signal word

WARNING

Section 2

SECTION 2: Hazards identification

Appearance: White, round, biconvex, bilayer tablets

Signal word

WARNING

Hazard statements

Harmful if swallowed.

Additional information

Short Term: Accidental ingestion may cause effects similar to those seen in clinical use. High doses of pseudoephedrine hydrochloride have been reported to cause increased blood pressure and/or heart rate. Known Clinical Effects: Accidental or incidental ingestion of cetirizine hydrochloride may cause sleepiness, dry mouth and fatigue. Adverse effects associated with the therapeutic use of pseudoephedrine hydrochloride include anxiety, restlessness, confusion, irritability, weakness, and gastrointestinal disturbances. EU Indication of danger: Harmful EU Hazard Symbols: EU Risk Phrases: R22 - Harmful if swallowed. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.